NEW YORK (dpa-AFX) - US bank JPMorgan has left its rating for Merck KGaA at "Overweight" with a target price of 190 euros ahead of the second quarter figures. The Electronics and Health Care segments should have compensated for a weak Life Sciences segment, analyst Richard Vosser wrote in an outlook published on Thursday. The Darmstadt-based company is likely to confirm its quantitative target for sales development this year. However, there could be shifts between the divisions./bek/mis

Publication of the original study: 17.07.2024 / 21:09 / BST

First dissemination of the original study: 18.07.2024 / 00:15 / BST

-----------------------

dpa-AFX Broker - the Trader News from dpa-AFX

-----------------------